Utility of extended HPV genotyping in cervical cancer screening and clinical management

Utility of extended HPV genotyping in cervical cancer screening and clinical management

Saved in:

Bibliographic Details
Main Authors:	Chengquan Zhao, Yuhong Ye, Terri E Jones
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2025-05-01
Series:	Gynecology and Obstetrics Clinical Medicine
Online Access:	https://gocm.bmj.com/content/5/2/e000226.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The challenges of cervical cancer screening for women aged over 65 years
by: Chengquan Zhao, et al.
Published: (2024-06-01)

Utility of extended HPV genotyping for the triage of self-sampled HPV-positive women in a screen-and-treat strategy for cervical cancer prevention in Cameroon: a prospective study of diagnostic accuracy
by: Pierre Vassilakos, et al.
Published: (2022-12-01)

Comprehensive overview of genotype distribution and prevalence of human papillomavirus in cervical lesions
by: Yang Liu, et al.
Published: (2024-04-01)

The impact of HPV/HIV co-infection on immunosuppression, HPV genotype, and cervical cancer biomarkers
by: Terkimbi Dominic Swase, et al.
Published: (2025-02-01)

The Clinical Role of HPV Testing in Primary and Secondary Cervical Cancer Screening
by: G. Hoste, et al.
Published: (2013-01-01)

Comparison of the SureX® HPV genotyping test with the Digene Hybrid Capture® 2 test in cervical cancer screening
by: Hehao Sun, et al.
Published: (2025-07-01)

Discontinuation of cervical cancer screening for HPV‐vaccinated women?
by: Jesper Bonde, et al.
Published: (2024-11-01)

Development, validation, and clinical application of a machine learning model for risk stratification and management of cervical cancer screening based on full-genotyping hrHPV test (SMART-HPV): a modelling studyResearch in context
by: Binhua Dong, et al.
Published: (2025-02-01)

Southern Vietnamese women’s views on HPV vaccination, cervical cancer screening, and HPV self-sampling
by: Minh Tung Phung, et al.
Published: (2025-08-01)

Cervical cancer trends, HPV vaccine utilization, and screening in low- and lower-middle-income countries: an updated review
by: Mohammad Khaled Iqbal Hamid, et al.
Published: (2025-07-01)

Extended HPV genotyping by the BD Onclarity assay: concordance with screening HPV-DNA assays, triage biomarkers, and histopathology in women from the NTCC2 study
by: Laura De Marco, et al.
Published: (2025-01-01)

Randomized controlled trial evaluating the utility of urine HPV DNA for cervical cancer screening in a Pacific Island population
by: Brenda Y. Hernandez, et al.
Published: (2018-07-01)

Comparative evaluation of Allplex HPV28 and Anyplex II HPV28 assays for high-risk HPV genotyping in cervical samples.
by: Sarah Mafi, et al.
Published: (2025-01-01)

Analysis of HPV genotype differences in different stages of cervical intraepithelial neoplasia
by: YU Jingmin, et al.
Published: (2024-11-01)

High frequency of HPV high-risk preventable genotypes in Ecuadorian women with invasive cervical cancer
by: Gustavo David García Muentes, et al.
Published: (2024-12-01)

Clinical performance of the SureX PCR HPV test versus hybrid capture assays (DH2/careHPV) in primary cervical cancer screening
by: Yumei Ouyang, et al.
Published: (2025-06-01)

HPV genotypes in invasive cervical cancer: prevalence, risk attribution, and optimized vaccine strategies in western China
by: Yuling Kou, et al.
Published: (2024-12-01)

Distribution of human papillomavirus genotypes by severity of cervical lesions in HPV screened positive women from the ESTAMPA study in Latin America.
by: Rita Mariel Correa, et al.
Published: (2022-01-01)

Serum profiling of the antibody response to HPV in women with or without abnormal cervical cytology undergoing cervical cancer screening
by: Radwa Ewaisha, et al.
Published: (2025-07-01)

HPV self-sampling for cervical cancer screening: a systematic review of values and preferences
by: Ping Teresa Yeh, et al.
Published: (2021-05-01)

Risk-based triage strategy by extended HPV genotyping for women with ASC-US cytology
by: Xuan Rao, et al.
Published: (2025-12-01)

Cervical cancer in India and HPV vaccination
by: K Kaarthigeyan
Published: (2012-01-01)

The Value of TruScreen (An Artificial Intelligence Cervical Cancer Screening System) in High-Risk HPV Positive Patients
by: Lianmei Luo, et al.
Published: (2023-10-01)

The potential role of HPV oncoproteins in the PD-L1/PD-1 pathway in cervical cancer: new perspectives on cervical cancer immunotherapy
by: Jin Li, et al.
Published: (2024-12-01)

Effectiveness Modelling and Economic Evaluation of Primary HPV Screening for Cervical Cancer Prevention in New Zealand.
by: Jie-Bin Lew, et al.
Published: (2016-01-01)

Application of GYPC gene methylation detection in cervical cancer screening for HR-HPV-positive women
by: LUO Haijun, LIAN Yixiang, WANG Zhigan, JIANG Shali
Published: (2025-02-01)

Advancements in Cervical Cancer Screening: Enhancing HPV Testing and Triage Strategies for Improved Risk Assessment
by: Yana Merdzhanova-Gargova, et al.
Published: (2025-07-01)

The incidence of high-risk HPV infections in Slovakia at the start of the national organized screening for cervical cancer
by: Erik Kudela, et al.
Published: (2025-06-01)

Utility of tryptase genotyping in the screening, diagnosis, and management of systemic mastocytosis
by: Jeremy C. McMurray, et al.
Published: (2025-05-01)

Cervical Cancer Screening Utilization and Barriers to Uptake in Ethiopia:
by: Ebrahim Mohammed MPH, PhD Fellow, et al.
Published: (2024-12-01)

Molecular Features of HPV-Independent Cervical Cancers
by: Luca Giannella, et al.
Published: (2025-07-01)

HPV infection and the immune microenvironment in cervical cancer
by: Yibo Li, et al.
Published: (2025-07-01)

Investigating the link between HPV genotypes and cervical abnormality incidence in women with HPV infections: insights from a leading referral centre
by: Zahra Sadeghi, et al.
Published: (2025-07-01)

The role of tumor-associated macrophages in HPV induced cervical cancer
by: Zeping Chen, et al.
Published: (2025-04-01)

HPV genotyping agreement between paired cervical cytological sample and biopsy across lesion severity and vaccination
by: Shimin Chen, et al.
Published: (2025-06-01)

Cervical cancer screening: Impact of collection technique on human papillomavirus detection and genotyping
by: Alisa P. Young, et al.
Published: (2025-02-01)

Comparing Diagnostic Efficacy of Pap Smear, Liquid-Based Cytology and HPV DNA in Cervical Cancer Screening
by: Priyanka Biradar, et al.
Published: (2025-06-01)

Barriers and facilitators to a combined strategy of HPV vaccination and cervical cancer screening among Mexican women
by: Leith León-Maldonado, et al.
Published: (2025-12-01)

Evaluation of hpv risk groups among women enrolled in the mulher cervical cancer screening study in Mozambique
by: Cristina Mendes de Oliveira, et al.
Published: (2025-04-01)

Innovative nomogram for cervical cancer prediction: integrating high-risk HPV infection, p53 genotype, and blood routine parameters
by: Cheng Sun, et al.
Published: (2025-05-01)